Vanda Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Vanda Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Vanda Pharmaceuticals Inc
Rating: 1.18902775
Author: Trendlyne DVM scores

Momentum Trap

about

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ f...

6.39 0.00 (0.00%)

35.71% Fall from 52W High

4,172

XNAS Volume

XNAS 15 May, 2026 9:25 AM (EDT)

Board Meeting

The next board meeting for Vanda Pharma Inc is on 20 May 2026 for the purpose of B. Riley Securities 26th Annual Investor Conference See details

Low Financial Strength

11.1 / 100

Expensive Valuation

26.5 / 100

Technically Neutral

46.4 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 133%

5 analysts

Vanda Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Vanda Pharma Inc Live Stock Price Today, Share Analysis and Chart

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ f...

35.71% Fall from 52W High

SWOT Analysis

Vanda Pharma Inc Live Price Chart